Amit Singh | |
---|---|
Born | India | March 18, 1976
Alma mater | |
Known for | Mycobacterium tuberculosis pathogenesis |
Awards | |
Scientific career | |
Fields | |
Institutions | |
Doctoral advisor |
|
Amit Singh (born 18 March 1976) is an Indian microbiologist and professor in the Department of Microbiology & Cell Biology at the Indian Institute of Science. His research focuses on pathogenesis, including drug resistance mechanisms in both mycobacterium tuberculosis (TB) and human immunodeficiency viruses (HIV).
Amit Singh was born on 18 March 1976. [1] He earned a Bachelor of Science from the University of Delhi, and a master's in Biotechnology from the Indian Institute of Technology Roorkee. [2] In 2004, he completed a PhD under the supervision of Professor Anil Kumar Tyagi at the University of Delhi South Campus. Subsequently, he conducted postdoctoral research in the lab of Dr. Adrie JC Steyn at the University of Alabama in Birmingham (UAB). [3]
Upon returning to India in 2010 Singh held a Wellcome Trust-DBT Intermediate Fellowship at the International Centre for Genetic Engineering and Biotechnology. In January of 2014 he became an assistant professor of microbiology and cell biology at the Indian Institute of Science (IISc). [4] He leads a research group at the Centre for Infectious Disease Research, [5] investigating the mechanisms of chronic human infections with a focus on Mycobacterium tuberculosis and human immunodeficiency virus (HIV). [6] [7] [8]
Singh has held a Wellcome Trust-DBT Senior Fellowship since 2016. [9] [10] He received the 2017/18 National Bioscience Award for Career Development from the Department of Biotechnology of the Government of India. [11]
Singh is a co-inventor on a patent titled "Shortening Tuberculosis Therapy and Reducing Relapse by Co-administering Chloroquine in TB and HIV-TB Co-infected Conditions," filed in 2020 and published in 2021.
In 2021, Singh was awarded the Shanti Swarup Bhatnagar Prize for Science and Technology for his contributions to understanding host-pathogen interactions in Mycobacterium tuberculosis and HIV. [12] In 2022, Singh was included in the Asian Scientist 100 list.